Latest EcoR1 Capital, LLC Stock Portfolio
$3.27Billion– No. of Holdings #55
EcoR1 Capital, LLC Performance:
2024 Q2: -13.92%YTD: -11.2%2023: -0.17%
Performance for 2024 Q2 is -13.92%, and YTD is -11.2%, and 2023 is -0.17%.
About EcoR1 Capital, LLC and 13F Hedge Fund Stock Holdings
EcoR1 Capital, LLC is a hedge fund based in SAN FRANCISCO, CA. On 29-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $4.7 Billions. In it's latest 13F Holdings report, EcoR1 Capital, LLC reported an equity portfolio of $3.3 Billions as of 30 Jun, 2024.
The top stock holdings of EcoR1 Capital, LLC are APLS, PRTA, SRPT. The fund has invested 13.6% of it's portfolio in APELLIS PHARMACEUTICALS INC and 7.3% of portfolio in PROTHENA CORP PLC.
The fund managers got completely rid off ALECTOR INC (ALEC), NKARTA INC (NKTX) and OVID THERAPEUTICS INC (OVID) stocks. They significantly reduced their stock positions in ACADIA PHARMACEUTICALS INC (ACAD), PROQR THRAPEUTICS N V and SAREPTA THERAPEUTICS INC (SRPT). EcoR1 Capital, LLC opened new stock positions in JANUX THERAPEUTICS INC (JANX), CARGO THERAPEUTICS INC and BICYCLE THERAPEUTICS PLC (BCYC). The fund showed a lot of confidence in some stocks as they added substantially to MORPHIC HLDG INC (MORF), ITEOS THERAPEUTICS INC (ITOS) and HOOKIPA PHARMA INC (HOOK).
The top stock holdings of EcoR1 Capital, LLC are APLS, PRTA, SRPT. The fund has invested 13.6% of it's portfolio in APELLIS PHARMACEUTICALS INC and 7.3% of portfolio in PROTHENA CORP PLC.
The fund managers got completely rid off ALECTOR INC (ALEC), NKARTA INC (NKTX) and OVID THERAPEUTICS INC (OVID) stocks. They significantly reduced their stock positions in ACADIA PHARMACEUTICALS INC (ACAD), PROQR THRAPEUTICS N V and SAREPTA THERAPEUTICS INC (SRPT). EcoR1 Capital, LLC opened new stock positions in JANUX THERAPEUTICS INC (JANX), CARGO THERAPEUTICS INC and BICYCLE THERAPEUTICS PLC (BCYC). The fund showed a lot of confidence in some stocks as they added substantially to MORPHIC HLDG INC (MORF), ITEOS THERAPEUTICS INC (ITOS) and HOOKIPA PHARMA INC (HOOK).
EcoR1 Capital, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
EcoR1 Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that EcoR1 Capital, LLC made a return of -13.92% in the last quarter. In trailing 12 months, it's portfolio return was -17.48%.
New Buys
| Ticker | $ Bought |
|---|---|
| janux therapeutics inc | 61,570,700 |
| cargo therapeutics inc | 24,137,400 |
| bicycle therapeutics plc | 18,418,400 |
| tectonic therapeutic inc | 13,985,400 |
| rocket pharmaceuticals inc | 10,945,700 |
| replimune group inc | 7,653,070 |
| atara biotherapeutics inc | 3,456,770 |
New stocks bought by EcoR1 Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| morphic hldg inc | 108 |
| iteos therapeutics inc | 62.55 |
| hookipa pharma inc | 24.42 |
| apellis pharmaceuticals inc | 2.2 |
| centessa pharmaceuticals plc | 1.7 |
Additions to existing portfolio by EcoR1 Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| acadia pharmaceuticals inc | -77.53 |
| proqr thrapeutics n v | -29.18 |
| sarepta therapeutics inc | -26.7 |
| atea pharmaceuticals inc | -11.45 |
EcoR1 Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| gossamer bio inc | -10,850,600 |
| ovid therapeutics inc | -18,658,100 |
| alector inc | -24,420,400 |
| nkarta inc | -21,620,000 |
| kodiak sciences inc | -8,487,540 |
| pmv pharmaceuticals inc | -963,694 |
| arcutis biotherapeutics inc | -4,955,000 |
| atara biotherapeutics inc | -7,055,930 |
EcoR1 Capital, LLC got rid off the above stocks
Sector Distribution
EcoR1 Capital, LLC has about 87.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 87.5 |
| Others | 12.5 |
Market Cap. Distribution
EcoR1 Capital, LLC has about 6.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 42 |
| MID-CAP | 36.1 |
| UNALLOCATED | 12.5 |
| LARGE-CAP | 6.8 |
| MICRO-CAP | 2.2 |
Stocks belong to which Index?
About 59.4% of the stocks held by EcoR1 Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 59.4 |
| Others | 40.6 |
EcoR1 Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of EcoR1 Capital, LLC
EcoR1 Capital, LLC has 55 stocks in it's portfolio. About 61.4% of the portfolio is in top 10 stocks. APLS proved to be the most loss making stock for the portfolio. SRPT was the most profitable stock for EcoR1 Capital, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACAD | acadia pharmaceuticals inc | 0.67 | 1,346,480 | 21,880,200 | reduced | -77.53 | ||
| ADAP | adaptimmune therapeutics plc | 0.82 | 27,404,100 | 26,716,200 | unchanged | 0.00 | ||
| ALEC | alector inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALGS | aligos therapeutics inc | 0.07 | 6,389,470 | 2,236,310 | unchanged | 0.00 | ||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALVR | allovir inc | 0.25 | 11,294,600 | 8,169,370 | unchanged | 0.00 | ||
| ANAB | anaptysbio inc | 5.77 | 7,521,020 | 188,477,000 | unchanged | 0.00 | ||
| APLS | apellis pharmaceuticals inc | 13.62 | 11,607,400 | 445,261,000 | added | 2.2 | ||
| ARQT | arcutis biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARVN | arvinas inc | 5.48 | 6,726,490 | 179,059,000 | unchanged | 0.00 | ||
| ATRA | atara biotherapeutics inc | 0.11 | 406,679 | 3,456,770 | new | |||
| ATRA | atara biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVIR | atea pharmaceuticals inc | 0.55 | 5,441,900 | 18,012,700 | reduced | -11.45 | ||
| BCYC | bicycle therapeutics plc | 0.56 | 910,000 | 18,418,400 | new | |||
| CLDX | celldex therapeutics inc | 0.74 | 650,000 | 24,056,500 | unchanged | 0.00 | ||
| CMAX | caremax inc | 0.01 | 100,000 | 279,000 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 1.58 | 5,714,400 | 51,601,100 | added | 1.7 | ||
| CRNX | crinetics pharmaceuticals in | 5.69 | 4,155,380 | 186,119,000 | unchanged | 0.00 | ||
| CRSP | crispr therapeutics ag | 2.30 | 1,389,280 | 75,034,800 | unchanged | 0.00 | ||
| DYN | dyne therapeutics inc | 0.46 | 427,039 | 15,070,200 | unchanged | 0.00 | ||